Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrially encoded tRNA histidine (MT-TH) is a transfer RNA located on the mitochondrial genome, responsible for transporting the amino acid histidine to the growing polypeptide chain during protein synthesis within mitochondria[3][1]. It consists of a small, 69-nucleotide RNA that contributes to the assembly of mitochondrial proteins, especially those involved in oxidative phosphorylation. Mutations in MT-TH can disrupt mitochondrial protein synthesis and are associated with several mitochondrial diseases, but MT-TH itself is not a receptor, enzyme, or drug target in the classic sense[1][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrially encoded tRNA histidine (MT-TH).